Lower Drug Costs for Families Act
Official title: A bill to amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Lower Drug Costs for Families Act
This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.
Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties.
The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
- Introduced in Senate Formatted Text PDF Formatted XML
Bodies those filers lobbied
Cite this page
U.S. Congress. (2026). S. 1186: Lower Drug Costs for Families Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-1186/
"S. 1186: Lower Drug Costs for Families Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-1186/.
S. 1186, 119th Cong. (2026), https://openamerica.io/bill/119-S-1186/.
[S. 1186: Lower Drug Costs for Families Act](https://openamerica.io/bill/119-S-1186/)